Product Information
SPRITAM 250 MG TABLET is a brand product labeled by Aprecia Pharmaceuticals, LLC, priced at $10.2722 per EA under NDC 43485010160. Its NADAC has been published 75 times since Mar 19, 2025.
FDA first approved this application on Jul 31, 2015.
The High Outlier badge above means this manufacturer's average price in the levetiracetam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Aprecia Pharmaceuticals, LLCNDC
43485010160
Classification
Brand
Dosage Form
TABLET, FOR SUSPENSION
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
LEVETIRACETAMApproval Type
New Drug (NDA)
FDA Application
NDA207958FDA Approved
7/31/2015
On Market Since
2/5/2016
Pharmacological Classes
Price Statistics
The NADAC for SPRITAM 250 MG TABLET has been published 75 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.2722 per EA |
|---|---|
| All-time high | $10.3926 (Apr 16, 2025) |
| All-time low | $10.2722 (Feb 18, 2026) |
| 52-week high | $10.3534 |
| 52-week low | $10.2722 |
| Median price | $10.3487 |
| Average price | $10.3244 |
| Largest weekly change | -0.6% (Feb 18, 2026) |
| Weeks tracked | 75 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SPRITAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SPRITAM 250 MG TABLET, manufactured by Aprecia Pharmaceuticals, LLC, is $10.2722 per EA (NDC 43485010160), effective Aug 19, 2026.
How has the price of SPRITAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for SPRITAM 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for SPRITAM 250 MG TABLET?
Since Mar 19, 2025, the NADAC for SPRITAM 250 MG TABLET has ranged from a low of $10.2722 (Feb 18, 2026) to a high of $10.3926 (Apr 16, 2025), with a median of $10.3487 per EA.
Are there cheaper alternatives to SPRITAM 250 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KEPPRA 250 MG TABLET, is $8.0786 per EA — about 21% below SPRITAM 250 MG TABLET.
Who manufactures SPRITAM 250 MG TABLET?
SPRITAM 250 MG TABLET (NDC 43485010160) is labeled by Aprecia Pharmaceuticals, LLC, and CMS classifies it as a brand product.